- contact@scirent.com
- +49 30 403688333+49
SCIRENT is a specialty CRO focused on cardiovascular research. We offer an excellent network of high-performing trial sites in Europe, regulatory consulting, as well as strong medical expertise in support of the design and execution of your programs
Meet us at
SCIRENT Patient recruitment experience & access
Heart Failure
(Including HFrEF, HFpEF and ADHF)
Chronic Myocarditis
Dilative and Hypertrophic Cardiomyopathy
Valvular Disease
Lipid disorders & Hypertension
Pulmonary Arterial Hypertension
Acute Ischemic Stroke
Atherosclerosis & CAD
Specialisation
>
1
%
Cardiovascular studies in a wide range of Patient profiles
Countries
1
+
Across Europe
Experience
1
yrs
Average experience in CV research of our team members
Focus
1
%
of the trials we conduct are in early phase development
Management
Leadership
Hans-Dirk Duengen PhD, MD, MBA
SCIRENT CEO and Scientific Director
Hans-Dirk Duengen is the founder and CEO of SCIRENT. He has collected a wealth of national and international experience in initiating and executing clinical trials as a senior cardiologist at the Charité University Hospital Berlin. Also, he is the author of numerous scientific publications.
Elvis Tahirovic, MBA, MPH
SCIRENT CEO and Managing Director
Elvis Tahirovic is a Co-founder and Managing Director at SCIRENT. He has more than 15 years of experience as a global project manager in the healthcare sector. He is responsible for the company’s business strategy and finances.
Jovan Veskovic, MPH, Dipl. Ecc
SCIRENT CFO and Director Eastern Europe
Jovan Veskovic is a Co-Founder and the Regional Director Eastern Europe at SCIRENT. Since the beginning, he brings in his know-how and passion for managing global clinical trials. He is a management executive with degrees in Public Health and Economics.
Maximilian Posch, MD, MPH
SCIRENT Chief Medical Officer
Maximilian Posch has a strong background in academic and industry-driven research. As a clinician of internal medicine and clinical pharmacology, he has profound expertise in early phase clinical trials and cardiovascular research. In his career, he conducted more than 200 trials and co-authored numerous peer-reviewed publications.
Book a meeting with our team
* required
If you have any problems with the form above, please get in touch with us directly: contact@scirent.com